注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
Tenaya Therapeutics Inc是一家臨床前階段的生物技術公司。該公司專注於發現、開發和提供治療性療法,以解決心髒病的潛在驅動因素。其正在推進一系列疾病修飾療法,這些療法是使用其產品平台和功能開發的,以針對患有罕見或其他流行形式的心髒病的患者的特定亞群。該公司正在推進來自基因治療、細胞再生和精準醫療等三種不同產品平台的候選產品。該公司還在推進包括基因療法和小分子在內的多樣化管道。該公司的能力包括疾病模型、衣殼工程、啟動子和監管要素、藥物輸送和製造。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Jin-Long Chen | 61 | 2016 | Independent Director |
David V. Goeddel | 72 | 2016 | Independent Chairman of the Board |
June H. Lee | 58 | 2021 | Independent Director |
Jeffrey T. Walsh | 58 | 2020 | Independent Director |
Douglas L. Mann | - | - | Member of Scientific Advisory Board |
Amy L. Burroughs | 53 | 2022 | Independent Director |
Alexander Marson | - | 2023 | Member of Scientific Advisory Board |
Elizabeth McNally | - | - | Member of Scientific Advisory Board |
R. Sanders Williams | 75 | 2016 | Independent Director |
Mark A. Kay | 65 | - | Member of Scientific Advisory Board |
Jonathan S. Weissman | - | - | Member of Scientific Advisory Board |
Karah Herdman Parschauer | 46 | 2021 | Independent Director |
Catherine Stehman-Breen | 61 | 2020 | Independent Director |
Christine Edry Seidman | - | 2023 | Member of Scientific Advisory Board |
Faraz Ali | 51 | 2018 | CEO & Director |
Eric N. Olson | - | - | Scientific Founder & Member of Scientific Advisory Board |
Deepak Srivastava | 57 | 2016 | Scientific Founder, Chairman of Scientific Advisory Board & Director |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核